Literature DB >> 193008

Cellular immunity and herpesvirus infections in cardiac-transplant patients.

K H Rand, L E Rasmussen, R B Pollard, A Arvin, T C Merigan.   

Abstract

We observed severe infection with herpes simplex virus in cardiac-transplant patients despite their high serum antibody levels to this virus. Therefore, we sought to correlate clinical susceptibility to two herpesvirus (simplex and zoster) infections with specific cellular immunity, assessed by the transformation and interferon responses of peripheral blood mononuclear cells to heat-inactivated antigens. Transformation and interferon response to herps simplex virus was maximally depressed immediately after transplantation, the time when severe and prolonged infection with herps simplex virus occurred. Six months to six years after transplantation, both clinical susceptibility and cellular immunity to herpes simplex virus were normal. Herpes zoster infections were more frequent than normal at all times after cardiac transplantation; depressed or absent cellular responses to the varicella zoster virus paralleled that susceptibility. In these patients the risk of severe herpesvirus infections correlated with depressed cellular immune responses to the specific viral agent involved.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 193008     DOI: 10.1056/NEJM197706162962402

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  34 in total

1.  Cellular and humoral immune responses to varicella-zoster virus in immunocompromised patients during and after varicella-zoster infections.

Authors:  A A Gershon; S P Steinberg
Journal:  Infect Immun       Date:  1979-07       Impact factor: 3.441

2.  Cell-mediated immunity to varicella-zoster virus measured by virus inactivation: mechanism and blocking of the reaction by specific antibody.

Authors:  A A Gershon; S P Steinberg
Journal:  Infect Immun       Date:  1979-07       Impact factor: 3.441

3.  Proliferative and interferon responses by peripheral blood mononuclear cells after bone marrow transplantation in humans.

Authors:  M J Levin; R Parkman; M N Oxman; J M Rappeport; M Simpson; P L Leary
Journal:  Infect Immun       Date:  1978-06       Impact factor: 3.441

4.  Age-dependent resistance of human alveolar macrophages to herpes simplex virus.

Authors:  L Mintz; W L Drew; R Hoo; T N Finley
Journal:  Infect Immun       Date:  1980-05       Impact factor: 3.441

5.  Axonal transport of herpes simplex virions to epidermal cells: evidence for a specialized mode of virus transport and assembly.

Authors:  M E Penfold; P Armati; A L Cunningham
Journal:  Proc Natl Acad Sci U S A       Date:  1994-07-05       Impact factor: 11.205

6.  The effects of cyclosporin A on the induction, expression and regulation of the immune response to herpes simplex virus.

Authors:  D M Altmann; W A Blyth
Journal:  Clin Exp Immunol       Date:  1985-01       Impact factor: 4.330

7.  Role of T lymphocytes in cellular immune responses during herpes simplex virus infection in humans.

Authors:  L Rasmussen; T C Merigan
Journal:  Proc Natl Acad Sci U S A       Date:  1978-08       Impact factor: 11.205

8.  Recombinant human Fab to glycoprotein D neutralizes infectivity and prevents cell-to-cell transmission of herpes simplex viruses 1 and 2 in vitro.

Authors:  R Burioni; R A Williamson; P P Sanna; F E Bloom; D R Burton
Journal:  Proc Natl Acad Sci U S A       Date:  1994-01-04       Impact factor: 11.205

9.  Cell-mediated and humoral immunity to herpesviruses during and after herpes zoster infections.

Authors:  O S Sørensen; S Haahr; A Møller-Larsen; K Wildenhoff
Journal:  Infect Immun       Date:  1980-08       Impact factor: 3.441

10.  Short-course human leukocyte interferon in treatment of herpes zoster in patients with cancer.

Authors:  T C Merigan; J G Gallagher; R B Pollard; A M Arvin
Journal:  Antimicrob Agents Chemother       Date:  1981-01       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.